$EGAN
EGAIN Corp

2023 Q4 Form 10-Q Financial Statement

#000155837023017979 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $23.82M $24.18M
YoY Change -6.97% -2.37%
Cost Of Revenue $6.990M $6.838M
YoY Change 3.52% 8.85%
Gross Profit $16.83M $17.34M
YoY Change -10.73% -6.18%
Gross Profit Margin 70.65% 71.72%
Selling, General & Admin $7.740M $9.290M
YoY Change -32.38% -24.33%
% of Gross Profit 46.0% 53.58%
Research & Development $6.660M $6.632M
YoY Change -7.35% -3.52%
% of Gross Profit 39.58% 38.25%
Depreciation & Amortization $94.00K $110.0K
YoY Change -24.8% -12.7%
% of Gross Profit 0.56% 0.63%
Operating Expenses $14.40M $15.92M
YoY Change -22.73% -16.86%
Operating Profit $2.425M $1.416M
YoY Change 1038.5% -311.34%
Interest Expense $982.0K $949.0K
YoY Change 85.63% 231.82%
% of Operating Profit 40.49% 67.02%
Other Income/Expense, Net -$697.0K $610.0K
YoY Change 27.89% -24.69%
Pretax Income $2.710M $2.975M
YoY Change 1275.63% 598.36%
Income Tax $525.0K $379.0K
% Of Pretax Income 19.37% 12.74%
Net Earnings $2.185M $2.596M
YoY Change -2200.96% -16325.0%
Net Earnings / Revenue 9.17% 10.74%
Basic Earnings Per Share $0.07 $0.08
Diluted Earnings Per Share $0.07 $0.08
COMMON SHARES
Basic Shares Outstanding 31.49M 31.48M
Diluted Shares Outstanding 31.84M 32.14M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $86.83M $79.80M
YoY Change 7.38% 11.57%
Cash & Equivalents $86.83M $79.83M
Short-Term Investments
Other Short-Term Assets $1.175M $1.304M
YoY Change 92.94% 147.91%
Inventory
Prepaid Expenses $2.157M $2.578M
Receivables $14.27M $18.42M
Other Receivables $0.00 $0.00
Total Short-Term Assets $105.7M $103.4M
YoY Change 4.15% 1.96%
LONG-TERM ASSETS
Property, Plant & Equipment $561.0K $551.0K
YoY Change -34.99% -32.14%
Goodwill $13.19M $13.19M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.768M $1.427M
YoY Change 75.57% 74.24%
Total Long-Term Assets $19.72M $19.60M
YoY Change -6.83% -7.71%
TOTAL ASSETS
Total Short-Term Assets $105.7M $103.4M
Total Long-Term Assets $19.72M $19.60M
Total Assets $125.4M $123.0M
YoY Change 2.26% 0.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.777M $853.0K
YoY Change 48.58% -55.96%
Accrued Expenses $4.207M $4.406M
YoY Change -17.43% 30.36%
Deferred Revenue $40.88M $41.96M
YoY Change -2.13% -6.06%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.29M $53.84M
YoY Change -3.98% -7.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $896.0K $833.0K
YoY Change 12.99% 15.37%
Total Long-Term Liabilities $896.0K $833.0K
YoY Change 12.99% 15.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.29M $53.84M
Total Long-Term Liabilities $896.0K $833.0K
Total Liabilities $58.65M $58.70M
YoY Change -4.33% -9.46%
SHAREHOLDERS EQUITY
Retained Earnings -$326.7M -$328.8M
YoY Change -2.1% -1.42%
Common Stock $404.4M $402.3M
YoY Change 1.59% 1.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.79M $64.27M
YoY Change
Total Liabilities & Shareholders Equity $125.4M $123.0M
YoY Change 2.26% 0.28%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $2.185M $2.596M
YoY Change -2200.96% -16325.0%
Depreciation, Depletion And Amortization $94.00K $110.0K
YoY Change -24.8% -12.7%
Cash From Operating Activities $7.696M $8.131M
YoY Change 3.79% 969.87%
INVESTING ACTIVITIES
Capital Expenditures $105.0K $32.00K
YoY Change -39.31% -73.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$105.0K -$32.00K
YoY Change -39.31% -73.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.628M -480.0K
YoY Change -266.97% -1700.0%
NET CHANGE
Cash From Operating Activities 7.696M 8.131M
Cash From Investing Activities -105.0K -32.00K
Cash From Financing Activities -1.628M -480.0K
Net Change In Cash 5.963M 6.626M
YoY Change -27.43% -1120.96%
FREE CASH FLOW
Cash From Operating Activities $7.696M $8.131M
Capital Expenditures $105.0K $32.00K
Free Cash Flow $7.591M $8.099M
YoY Change 4.82% 1165.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001066194
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
001-35314
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
eGain Corporation
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0466366
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
1252 Borregas Avenue
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Sunnyvale
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94089
CY2023Q3 dei City Area Code
CityAreaCode
408
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
636-4500
CY2023Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q3 dei Trading Symbol
TradingSymbol
EGAN
CY2023Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31485186
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79827000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73201000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
121000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
237000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18420000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31569000
CY2023Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1231000
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1317000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2578000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2466000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1304000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1268000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
103367000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
109828000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
551000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
633000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2497000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2797000
CY2023Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1938000
CY2023Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
2318000
CY2023Q3 us-gaap Goodwill
Goodwill
13186000
CY2023Q2 us-gaap Goodwill
Goodwill
13186000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1427000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1355000
CY2023Q3 us-gaap Assets
Assets
122966000
CY2023Q2 us-gaap Assets
Assets
130117000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
853000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2044000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5931000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7697000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4406000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5387000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
689000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
832000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41959000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47762000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
53838000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
63722000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2413000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2101000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1617000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1762000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
833000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
836000
CY2023Q3 us-gaap Liabilities
Liabilities
58701000
CY2023Q2 us-gaap Liabilities
Liabilities
68421000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32269000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32268000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31400000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31482000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
32000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
32000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
402299000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
401087000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
869000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
786000
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
6280000
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
5763000
CY2023Q3 egan Notes Receivable From Stockholders
NotesReceivableFromStockholders
64000
CY2023Q2 egan Notes Receivable From Stockholders
NotesReceivableFromStockholders
97000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2877000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2122000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-328845000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-331441000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
64265000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
61696000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
122966000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130117000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24176000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24763000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6838000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6282000
CY2023Q3 us-gaap Gross Profit
GrossProfit
17338000
CY2022Q3 us-gaap Gross Profit
GrossProfit
18481000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6632000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6874000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6104000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9459000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3186000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2818000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
15922000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
19151000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1416000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-670000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
949000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
286000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
610000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
810000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2975000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
426000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
379000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
442000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2596000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-16000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31479000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31933000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32136000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31933000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2596000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-16000
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-151000
CY2023Q3 egan Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-284000
CY2022Q3 egan Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-255000
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
16000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-755000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1151000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1841000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1167000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
61696000
CY2023Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
33000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
517000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1208000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-755000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2596000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
64265000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
56857000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2065000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1151000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-16000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
57785000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
2596000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-16000
CY2023Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
500000
CY2022Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
375000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
294000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
272000
CY2023Q3 egan Depreciation And Amortization Of Capital Lease Assets
DepreciationAndAmortizationOfCapitalLeaseAssets
107000
CY2022Q3 egan Depreciation And Amortization Of Capital Lease Assets
DepreciationAndAmortizationOfCapitalLeaseAssets
126000
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-110000
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
84000
CY2023Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
45000
CY2022Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-14000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1208000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2065000
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13100000
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1530000
CY2023Q3 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
89000
CY2022Q3 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
191000
CY2023Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
131000
CY2022Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
824000
CY2023Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
44000
CY2022Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-355000
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
31000
CY2022Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-12000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1182000
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
249000
CY2023Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1706000
CY2022Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1375000
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-944000
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1463000
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5124000
CY2022Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-47000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8131000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
760000
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
120000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-120000
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30000
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
517000
CY2023Q3 egan Proceeds From Repayment Of Notes Receivable Due From Stockholders
ProceedsFromRepaymentOfNotesReceivableDueFromStockholders
33000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-480000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30000
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-993000
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1319000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6626000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-649000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73208000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72180000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79834000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71531000
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
863000
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
489000
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18000
CY2022Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
30000
CY2023Q3 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Organization and Nature of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">eGain Corporation (eGain, the Company, our, we or us) automates customer engagement with an innovative knowledge hub, powered by conversational artificial intelligence (AI) and analytics. We sell mostly to large enterprises across financial services, telecommunications, retail, government, healthcare, and utilities seeking to better serve customers at scale while coping with content silos, process complexity, and regulatory compliance. With our mantra of <b style="font-weight:bold;">AX + BX + CX = DX™</b>, we guide clients to effortless digital experience (DX) by holistically optimizing agent experience (AX), business experience (BX), and customer experience (CX). Leading brands use eGain’s cloud software to improve customer satisfaction, empower agents, reduce service cost, and boost sales. We are headquartered in the United States. We also operate in the United Kingdom and India.</p>
CY2023Q3 us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Fiscal Year</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company fiscal year ends on June 30. References to fiscal year 2024 refers to fiscal year ending June 30, 2024.</p>
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The preparation of financial statements requires us to make estimates and assumptions in the condensed consolidated financial statements and accompanying notes. Actual results could differ significantly from estimates. We make estimates </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">that we believe to be reasonable based on historical experience and other assumptions. Significant estimates and assumptions made by management include the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Standalone selling price (SSP) of performance obligations for contracts with multiple performance obligations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Estimate of variable consideration for performance obligations in connection with Topic 606;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Period of benefit associated with capitalized costs to obtain revenue contracts;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Valuation, measurement and recognition of current and deferred income taxes;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Fair value of stock-based awards; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Lease term and incremental borrowing rate for lease liabilities.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
CY2022Q3 egan Number Of Revenue Categories
NumberOfRevenueCategories
2
CY2023Q3 egan Number Of Revenue Categories
NumberOfRevenueCategories
2
CY2023Q3 egan Revenue Payment Term Minimum
RevenuePaymentTermMinimum
P30D
CY2023Q3 egan Revenue Payment Term Maximum
RevenuePaymentTermMaximum
P45D
CY2023Q3 egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
89000
CY2022Q3 egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
191000
CY2023Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
500000
CY2022Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
375000
CY2023Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3200000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3600000
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 egan Number Of Operating Regions
NumberOfOperatingRegions
3
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1416000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-670000
CY2023Q3 us-gaap Noncurrent Assets
NoncurrentAssets
551000
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
633000
CY2023Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Concentration of Credit Risk and Significant Customers </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our financial instruments that are exposed to concentrations of credit risk include cash and cash equivalents, restricted cash, and accounts receivable. <span style="background:#ffffff;">We complement direct sales with resell partnerships based on product connectors into cloud contact center platforms. We also partner with system integrators and managed service providers.</span> Two customers, who are also our partners, accounted for 17% and 11%, respectively, of total revenue during the three months ended September 30, 2023. One customer, who is also our partner, accounted for 24% of total revenue during the three months ended September 30, 2022. Two and three different customers accounted for more than 10% of our gross accounts receivable, less provision for credit losses balance as of September 30, 2023 and 2022, respectively.</p>
CY2023Q3 egan Number Of Customers And Partners That Accounted For More Than Ten Percentage Of Revenue
NumberOfCustomersAndPartnersThatAccountedForMoreThanTenPercentageOfRevenue
2
CY2022Q3 egan Number Of Customers And Partners That Accounted For More Than Ten Percentage Of Revenue
NumberOfCustomersAndPartnersThatAccountedForMoreThanTenPercentageOfRevenue
1
CY2023Q3 egan Number Of Customers That Accounted For More Than Ten Percent Of Companys Accounts Receivable
NumberOfCustomersThatAccountedForMoreThanTenPercentOfCompanysAccountsReceivable
2
CY2022Q3 egan Number Of Customers That Accounted For More Than Ten Percent Of Companys Accounts Receivable
NumberOfCustomersThatAccountedForMoreThanTenPercentOfCompanysAccountsReceivable
3
CY2023Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1100000
CY2023Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1700000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1208000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2065000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24176000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24763000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24176000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24763000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24176000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24763000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41959000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47762000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2413000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2101000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44372000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
49863000
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12900000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
82400000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
59700000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22700000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2596000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-16000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31479000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31933000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
657000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32136000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31933000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
326000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
321000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
315000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
298000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2497000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2797000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
689000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
832000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1617000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1762000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M25D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0499
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0497
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
618000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
668000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
688000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
527000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2501000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
195000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2306000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
689000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1617000
CY2023Q3 egan Warranty Period Maximum
WarrantyPeriodMaximum
P1Y
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
13700000
CY2022Q4 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P1Y
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
83056
CY2023Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
6.23
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
517000
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
egan-20230930_cal.xml Edgar Link unprocessable
0001558370-23-017979-index-headers.html Edgar Link pending
0001558370-23-017979-index.html Edgar Link pending
0001558370-23-017979.txt Edgar Link pending
0001558370-23-017979-xbrl.zip Edgar Link pending
egan-20230930.xsd Edgar Link pending
egan-20230930x10q.htm Edgar Link pending
egan-20230930xex31d1.htm Edgar Link pending
egan-20230930xex31d2.htm Edgar Link pending
egan-20230930xex32d1.htm Edgar Link pending
egan-20230930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
egan-20230930_def.xml Edgar Link unprocessable
egan-20230930_lab.xml Edgar Link unprocessable
egan-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
egan-20230930x10q_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending